Ready 8-Ks
28
Latest filing
June 3, 2026, 9:08 PM ET
Top materiality
0.85
Event mix
earnings ×10 · other_material ×6 · debt ×6
Sentiment
19 pos · 1 neg · 8 neu
Latest earnings
reported 2026-Q1
-
RadNet announces proposed $200M incremental term loan for acquisitions and growth
Seeks $200 million incremental term loan under existing credit agreement, maturing April 18, 2031.
-
RadNet Q1 revenue $575.6M (+22.1%), adj. EBITDA $63.3M (+36.3%); raises FY guidance
Total Revenue $575.6M, up 22.1% YoY; Adjusted EBITDA $63.3M, up 36.3% YoY.
-
RadNet acquires Gleamer for up to €230M; DeepHealth becomes largest radiology AI provider
All-cash deal includes ~€215M closing payment and up to €15M milestone-based contingent payment.
-
RadNet Q4 revenue $547.7M record; Adj. EBITDA $87.7M record; issues 17-22% growth guide for 2026
Q4 2025 revenue $547.7M (+14.8% YoY); Adj. EBITDA $87.7M (+16.9% YoY) - both quarterly records.
-
RadNet Q3 revenue $522.9M (+13.4% YoY), adj. EBITDA $84.9M (+15.2%), raises FY2025 guidance
Total revenue $522.9M vs $461.1M a year ago; adjusted EPS $0.20 (up from $0.18).
-
RadNet Q2 revenue $498.2M (+8.4% YoY), record Adj. EBITDA $81.2M; raises FY2025 guidance
Q2 revenue $498.2M (+8.4% YoY), Adjusted EBITDA $81.2M (record, +12.3%), margin up 57bps to 16.3%.
-
RadNet completes iCAD acquisition via DeepHealth subsidiary; expands AI breast health
DeepHealth, RadNet's digital health segment, closed acquisition of iCAD (NASDAQ: ICAD).
-
RadNet Q1 revenue up 9.2% to $471M, net loss $37.9M; raises 2025 revenue and EBITDA guidance
Revenue $471.4M (+9.2% YoY); Adjusted EBITDA $46.4M (-20.6% YoY) hit by $22M revenue and $15M EBITDA from SoCal wildfires and winter weather.
-
RadNet to acquire iCAD for ~$103M all-stock; ~98% premium
All-stock acquisition of iCAD for ~$103M (0.0677 RDNT shares per ICAD share); ~98% premium to ICAD's April 14 close.
-
RadNet Q4 revenue $477M (+13.5%), Adj EBITDA $75M record; FY2025 guidance issued
Q4 revenue $477.1M (+13.5% y/y), Adjusted EBITDA $75.0M (+14.0%), both quarterly records.
-
RadNet amends credit facility, reducing interest rates by 0.25% on $872.8M term loans
Interest rate on term loans reduced to Term SOFR + 2.25% or base rate + 1.25%.
-
RadNet reports record Q3 revenue $461.1M (+14.7%), raises 2024 guidance
Revenue $461.1M (+14.7% YoY); Adj. EBITDA $73.7M (+27.2%); adjusted EPS $0.18 vs $0.13.
-
RadNet Digital Health segment revenue up 34% in H1 2024; AI revenue grows 128% YoY
Full-year Digital Health revenue guidance of $60-70M with adjusted EBITDA of $13-15M.
-
RadNet appoints Kees Wesdorp as President & CEO of Digital Health segment effective Oct 1, 2024
Wesdorp will lead eRAD, DeepHealth OS and AI solutions under the Digital Health division.
-
RadNet Q2 revenue $459.7M (+13.9% YoY), adj. EBITDA $72.3M (+19.7%), raises FY2024 guidance
Adjusted diluted EPS $0.16 vs $0.10 YoY; GAAP net loss $3.0M due to $8.8M debt refinancing costs.
-
RadNet Q1 revenue $431.7M (+10.5% YoY); adjusted EBITDA $58.5M (+21.4%); raises 2024 guidance
Q1 net loss $(0.04)/share vs $(0.36) last year; adjusted EPS $0.07 vs $(0.22).
-
RadNet closes $875M term loan and $282M revolver refinancing, extends maturities
New $875M senior secured term loan matures April 2031; revolver of $282M matures April 2029.
-
RadNet prices $875M term loan and $282M revolver in upsized refinancing
$875M term loan (up from $840M) at SOFR+2.50%, 7-yr maturity; $282M revolver (up from $250M), 5-yr term.
-
RadNet proposes $840M term loan and $250M revolver to refinance existing debt, add $148M for growth
RadNet plans $840M term loan (7-yr) and $250M revolver (5-yr), replacing $679M due 2028 and $195M due 2026.
-
RadNet closes $230.2M common stock offering (5.23M shares at $44.00/share)
Closed public offering of 5,232,500 shares at $44.00/share, including full exercise of underwriters' option for 682,500 additional shares.
-
RadNet Q4 revenue record $420.4M (+9.5%), Adj. EBITDA $65.8M (+15%); guides 2024 higher
Q4 revenue $420.4M (+9.5% YoY); Imaging Center revenue $415.3M (+8.6%); total Adj. EBITDA $65.8M (+15%)